Brief: Huakang Biomedical Sees A Loss Attributable Of About RMB1.1 Million For Three Months
29/04/2021 11:37
April 29 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* HUAKANG BIOMEDICAL SEES A LOSS ATTRIBUTABLE OF ABOUT
RMB1.1
MILLION FOR THREE MONTHS
* EXPECTED RESULT DUE TO INCREASE IN GROUP'S REVENUE OF
ABOUT
RMB2.8 MILLION
Source text for Eikon: ID:nHKS1xRg54
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology